Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHLW Panel Designates Early Introduction for Vagus Nerve Stimulator Implant

This article was originally published in PharmAsia News

Executive Summary

The panel for the early introduction of medical devices in high demand at the Ministry of Health, Labor and Welfare designated the implant Vagus nerve stimulator as a technology that merits early introduction and is targeted for fast track review. Imported by Japanese medical device maker Nihon Kohden, the device will be given an expedited review upon receipt of application. VNS therapy has been approved in 64 countries for use in treatment-resistant epilepsy and in treatment-resistant depression. Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel